Guest: Gregory Barsness, M.D
Host: Malcolm Bell, M.D
Objectives:
Chronic (better than 3 months) full epicardial coronary obstructive lesions, also known as CTOs, are acknowledged in a big minority of these referred for coronary angiography but traditionally signify lower than 5% of coronary intervention makes an attempt. Improving instruments, methods and methods have allowed better entry to percutaneous administration of symptomatic coronary illness with improved procedural security and technical and scientific success.
Topics Discussed:
What is a CTO and who do they have an effect on?
What are the administration choices for these with CTO?
How are candidates for CTO PCI recognized?
What are the dangers and anticipated scientific advantages of CTO PCI and might these be anticipated and outcomes optimized?
What does the long run maintain for these with symptomatic continual coronary occlusions?
